Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Analysis of the Micro-RNA-133 and PITX3 genes in Parkinson's disease.

de Mena L, Coto E, Cardo LF, Díaz M, Blázquez M, Ribacoba R, Salvador C, Pastor P, Samaranch L, Moris G, Menéndez M, Corao AI, Alvarez V.

Am J Med Genet B Neuropsychiatr Genet. 2010 Sep;153B(6):1234-9. doi: 10.1002/ajmg.b.31086.

PMID:
20468068
2.

Mutational screening of the mortalin gene (HSPA9) in Parkinson's disease.

De Mena L, Coto E, Sánchez-Ferrero E, Ribacoba R, Guisasola LM, Salvador C, Blázquez M, Alvarez V.

J Neural Transm (Vienna). 2009 Oct;116(10):1289-93. doi: 10.1007/s00702-009-0273-2. Epub 2009 Aug 6.

PMID:
19657588
3.

Therapeutic extradural cortical stimulation for Parkinson's Disease: report of six cases and review of the literature.

Gutiérrez JC, Seijo FJ, Alvarez Vega MA, Fernández González F, Lozano Aragoneses B, Blázquez M.

Clin Neurol Neurosurg. 2009 Oct;111(8):703-7. doi: 10.1016/j.clineuro.2009.06.006. Epub 2009 Jul 14. Review.

PMID:
19604625
4.

Lrrk2 R1441G-related Parkinson's disease: evidence of a common founding event in the seventh century in Northern Spain.

Mata IF, Hutter CM, González-Fernández MC, de Pancorbo MM, Lezcano E, Huerta C, Blazquez M, Ribacoba R, Guisasola LM, Salvador C, Gómez-Esteban JC, Zarranz JJ, Infante J, Jankovic J, Deng H, Edwards KL, Alvarez V, Zabetian CP.

Neurogenetics. 2009 Oct;10(4):347-53. doi: 10.1007/s10048-009-0187-z. Epub 2009 Mar 24.

5.

5'-Upstream variants of CRHR1 and MAPT genes associated with age at onset in progressive supranuclear palsy and cortical basal degeneration.

Cruchaga C, Vidal-Taboada JM, Ezquerra M, Lorenzo E, Martinez-Lage P, Blazquez M, Tolosa E; Iberian Atypical Parkinsonism Study Group Researchers, Pastor P.

Neurobiol Dis. 2009 Feb;33(2):164-70. doi: 10.1016/j.nbd.2008.09.027. Epub 2008 Nov 1.

PMID:
19022385
6.

Mutational screening of the mitochondrial transcription factors B1 and B2 (TFB1M and TFB2M) in Parkinson's disease.

Sánchez-Ferrero E, Coto E, Blázquez M, Ribacoba R, Guisasola LM, Salvador C, Alvarez V.

Parkinsonism Relat Disord. 2009 Jul;15(6):468-70. doi: 10.1016/j.parkreldis.2008.09.004. Epub 2008 Nov 5.

PMID:
18980857
7.

Mitochondrial transcription factor A (TFAM) gene variation in Parkinson's disease.

Alvarez V, Corao AI, Sánchez-Ferrero E, De Mena L, Alonso-Montes C, Huerta C, Blázquez M, Ribacoba R, Guisasola LM, Salvador C, García-Castro M, Coto E.

Neurosci Lett. 2008 Feb 13;432(1):79-82. doi: 10.1016/j.neulet.2007.12.010. Epub 2007 Dec 15.

PMID:
18248889
8.

Pathogenicity of the Lrrk2 R1514Q substitution in Parkinson's disease.

Toft M, Mata IF, Ross OA, Kachergus J, Hulihan MM, Haugarvoll K, Stone JT, Blazquez M, Gibson JM, Aasly JO, White LR, Lynch T, Adler CH, Gwinn-Hardy K, Farrer MJ.

Mov Disord. 2007 Feb 15;22(3):389-92.

PMID:
17216639
9.

No association between Parkinson's disease and three polymorphisms in the eNOS, nNOS, and iNOS genes.

Huerta C, Sánchez-Ferrero E, Coto E, Blázquez M, Ribacoba R, Guisasola LM, Salvador C, Alvarez V.

Neurosci Lett. 2007 Feb 21;413(3):202-5. Epub 2006 Dec 15.

PMID:
17174475
10.

Digenic parkinsonism: investigation of the synergistic effects of PRKN and LRRK2.

Dächsel JC, Mata IF, Ross OA, Taylor JP, Lincoln SJ, Hinkle KM, Huerta C, Ribacoba R, Blazquez M, Alvarez V, Farrer MJ.

Neurosci Lett. 2006 Dec 20;410(2):80-4.

PMID:
17095157
11.

Mitochondrial DNA polymorphisms and risk of Parkinson's disease in Spanish population.

Huerta C, Castro MG, Coto E, Blázquez M, Ribacoba R, Guisasola LM, Salvador C, Martínez C, Lahoz CH, Alvarez V.

J Neurol Sci. 2005 Sep 15;236(1-2):49-54.

PMID:
15975594
12.

LRRK2 R1441G in Spanish patients with Parkinson's disease.

Mata IF, Taylor JP, Kachergus J, Hulihan M, Huerta C, Lahoz C, Blazquez M, Guisasola LM, Salvador C, Ribacoba R, Martinez C, Farrer M, Alvarez V.

Neurosci Lett. 2005 Jul 15;382(3):309-11. Epub 2005 Apr 13.

PMID:
15925109
13.

Homozygous partial genomic triplication of the parkin gene in early-onset parkinsonism.

Mata IF, Alvarez V, Coto E, Blazquez M, Guisasola LM, Salvador C, Kachergus JM, Lincoln SJ, Farrer M.

Neurosci Lett. 2005 Jun 3;380(3):257-9. Epub 2005 Feb 8.

PMID:
15862897
14.

Chemokines (RANTES and MCP-1) and chemokine-receptors (CCR2 and CCR5) gene polymorphisms in Alzheimer's and Parkinson's disease.

Huerta C, Alvarez V, Mata IF, Coto E, Ribacoba R, Martínez C, Blázquez M, Guisasola LM, Salvador C, Lahoz CH, Peña J.

Neurosci Lett. 2004 Nov 11;370(2-3):151-4.

PMID:
15488313
15.

[The Guillain-Barré syndrome due to cytomegalovirus in two siblings. Peak-flow meter as the mechanism of transmission].

Blázquez M, López-Alburquerque T, Ciudad Bautista J, Fermoso García J.

Med Clin (Barc). 2002 Sep 14;119(8):317-8. Spanish. No abstract available.

PMID:
12236978
16.

Single-nucleotide polymorphisms in the promoter region of the PARKIN gene and Parkinson's disease.

Mata IF, Alvarez V, García-Moreira V, Guisasola LM, Ribacoba R, Salvador C, Blázquez M, Sarmiento RG, Lahoz CH, Menes BB, García EC.

Neurosci Lett. 2002 Aug 30;329(2):149-52.

PMID:
12165399

Supplemental Content

Loading ...
Support Center